Terumo Blood and Cell Applied sciences (Terumo BCT), a medical know-how firm and world chief in blood administration options, introduced the adoption of a number of Reveos™ Automated Blood Processing Programs by Ribeirão Preto Blood Middle, the high-volume blood community supporting about 120,000 transfusions a 12 months in São Paulo. Ribeirão Preto will function a reference heart for different facilities in Brazil, with Terumo BCT aiding native operators in implementing automated processing as a part of a drive to modernize public transfusion drugs in Brazil.
Like many areas, São Paulo is confronting a big well being problem: The necessity for blood and blood merchandise is rising, however donation charges are contracting. In 2025, Ribeirão Preto supported 119,000 transfusions, a 3.5% enhance over the earlier 12 months, with a rise in demand for blood element items as effectively. In the meantime, donations dropped by about 2% in that point, persevering with a development seen since 2019 that isn’t anticipated to reverse.
To deal with the rising disparity, the blood heart is shifting to modernize its infrastructure by way of automation and standardization, leveraging the Reveos methods to enhance effectivity and meet the excessive demand for blood elements whereas assuaging constraints associated to staffing, house and budgets. The middle will transition its entire blood processing workflow from a semi-automated mannequin to a completely automated and built-in operation, producing merchandise like plasma to handle bleeding and clotting and platelets to assist deal with sufferers with most cancers. As a part of this transition, Ribeirão Preto Blood Middle will enhance its use of leukoreduction throughout its blood processing operations. Leukoreduction is a course of that may assist scale back sure transfusion-related problems.
The work at Ribeirão Preto demonstrates that superior automation could be adopted in a public blood service when operational wants and long-term useful resource planning come collectively.The venture additionally demonstrates the worth of innovating blood processing to different facilities throughout Brazil, displaying what is feasible with a extra related method to blood processing.”
Eduardo Morato, Nation Supervisor, Brazil and Latin America Distributors, Terumo Blood and Cell Applied sciences
The organizations have collaborated for many years, as Ribeirão Preto Blood Middle has lengthy relied on different Terumo BCT platforms, together with the Trima Accel™ Automated Blood Assortment System and the Spectra Optia™ Apheresis System. By ecosystem connectivity, the venture has the potential to combine info from Terumo BCT platforms throughout assortment and processing, serving to present larger visibility into blood items and elements produced, processing actions and operational efficiency. As the primary main Reveos venture in Brazil and the primary in a public blood heart, Ribeirão Preto can be anticipated to function a reference heart for different public blood companies concerned with automation.
Ribeirão Preto Blood Middle is a number one transfusion drugs and hematology heart in Brazil and serves as a reference for high quality, affected person care, training and analysis. Its community helps blood assortment, processing and distribution throughout a broad portion of São Paulo State.
Supply:
Terumo Blood and Cell Applied sciences
